Skip to main content

Table 1 Clinical information for lung adenocarcinoma samples profiled

From: Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology

Characteristic NS1 CS2 FS3
Number 27 43 24
Sex    
Male 7 (26%) 13 (30%) 9 (38%)
Female 20 (74%) 30 (70%) 15 (62%)
Average age 71 64 71
Stage    
I 16 (59%) 26 (60%) 16 (67%)
II 6 (22%) 11 (26%) 6 (25%)
III 5 (19%) 4 (9%) 1 (4%)
IV 0 2 (5%) 1 (4%)
Ethnicity    
Caucasian 8 (30%) 11 (26%) 1 (4%)
Asian 16 (59%) 0 (0%) 0 (0%)
Unknown 3 (11%) 32 (74%) 23 (96%)
Average pack years 0 46 47
Average years quit n/a < 1 15
  1. 1NS as patients who smoked fewer than 100 cigarettes in their lifetime. 2CS were defined as smoking at the time of diagnosis. 3FS as individuals who had stopped smoking at least one year prior to diagnosis.
\